Cullinan Therapeutics (CGEM) Earnings Date & Reports
Cullinan Therapeutics Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CGEM is expected to report earnings to rise 13.49% to -87 cents per share on March 05
Q4'25
Est.
$-0.87
Q3'25
Beat
by $0.18
Q2'25
Missed
by $0.25
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.06
The last earnings report on November 06 showed earnings per share of -76 cents, beating the estimate of -94 cents. With 255.78K shares outstanding, the current market capitalization sits at 493.29M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGEM showed earnings on November 06, 2025. You can read more about the earnings report here.